Discover
ARVN
Arvinas, Inc.
8.20
2 x 5.97
2 x 10.36
bid
ask
-
0.11
1.32%
2 @ 06:20 AM
8.11 -0.09 (1.10%)
| Ytd | -30.86% | |
| 1y | 7.47% |
8.01
day range
8.44
6.06
52 week range
14.51
| Open | 8.30 | Prev Close | 8.31 | Low | 8.01 | High | 8.44 | Mkt Cap | 529.07M |
| Vol | 691.62K | Avg Vol | 857.23K | EPS | -3.18 | P/E | N/A | Forward P/E | -1.78 |
| Beta | 1.96 | Short Ratio | 11.90 | Inst. Own | 110.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.86 | 200-d Avg | 10.67 | 1yr Est | 58.55 |
ARVN News
benzinga.com
Rigel Pharmaceuticals Closes Its Licensing Agreement for VEPPANU; The Agreement Is Effective As Of J
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a commercial stage biotechnology company focused on hemat
benzinga.com
Stephens & Co. Reiterates Overweight on Arvinas, Maintains $18 Price Target
Stephens & Co. analyst Sudan Loganathan reiterates Arvinas (NASDAQ:ARVN) with a Overweight an
benzinga.com
Arvinas Announces Re-Prioritization Of Portfolio Following Strategic Review; Plans To Complete Phase
Following a strategic review of its pipeline, the Company has made the decision to re-prioritize its
benzinga.com
Full Transcript: Arvinas Q1 2026 Earnings Call